- Docket No.
- 2:23-cv-00836
- District Court
- Western District of Pennsylvania
Goal
- Compensatory damages
- Exemplary and punitive damages
- Treble damages
Issues
Litigation Content
Why this Matters:
The plaintiffs argue that defendants improperly listed certain patents in the Orange Book to maintain exclusivity and block other generics from entering the market in violation of federal patent and antitrust law. Patent abuses can distort the market for prescription drugs and drive up prices for consumers.
Potential Impact:
Improper patent listings in the Orange Book can undermine fair competition and prohibit or delay consumers from accessing lower-cost generic drugs.
14 Major Filings
- DEFENDANTS’ RESPONSE TO PLAINTIFFS’ THIRD NOTICE OF SUPPLEMENTAL AUTHORITY (Aug 12, 2024)
- PLAINTIFFS’ NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF ITS OPPOSITION TO DEFENDANTS’ MOTION TO DISMISS (Aug 9, 2024)
- PLAINTIFFS’ RESPONSE TO DEFENDANTS’ NOTICE OF SUPPLEMENTAL AUTHORITY (Jun 18, 2024)
- DEFENDANTS’ NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF MOTION TO DISMISS PLAINTIFFS’ COMPLAINT (Jun 11, 2024)
- PLAINTIFFS’ REPLY IN SUPPORT OF NOTICE OF SUPPLEMENTAL AUTHORITY (Mar 6, 2024)
- DEFENDANTS’ RESPONSE TO PLAINTIFFS’ SECOND NOTICE OF SUPPLEMENTAL AUTHORITY (Feb 20, 2024)
- PLAINTIFFS’ NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF ITS OPPOSITION TO DEFENDANTS’ MOTION TO DISMISS (Feb 13, 2024)
- REPLY MEMORANDUM IN SUPPORT OF DEFENDANTS’ MOTION TO DISMISS PLAINTIFFS’ COMPLAINT (Dec 11, 2023)
- PLAINTIFF’S NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF ITS OPPOSITION TO DEFENDANTS’ MOTION TO DISMISS (Dec 1, 2023)
- FEDERAL TRADE COMMISSION’S BRIEF AS AMICUS CURIAE (Nov 21, 2023)
- PLAINTIFFS’ RESPONSE IN OPPOSITION TO DEFENDANTS’ MOTION TO DISMISS (Nov 13, 2023)
- MEMORANDUM IN SUPPORT OF DEFENDANTS’ MOTION TO DISMISS PLAINTIFFS’ COMPLAINT (Sep 15, 2023)
- DEFENDANTS’ MOTION TO DISMISS PLAINTIFFS’ COMPLAINT (Sep 15, 2023)
- COMPLAINT (May 17, 2023)